Effect of fever on the serum antibody response of Gambian children to Haemophilus influenzae type b conjugate vaccine

Pediatric Infectious Disease Journal

Volumn 19, Issue 5, 2000, Pages 444-449

  Usen, Stanley ^d   Milligan, Paul ^e   Ethevenaux, Chantal ^a   Greenwood, Brian ^b   Mulholland, Kim ^c  

^a SANOFI PASTEUR   (France)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

^d BROOKLYN HOSPITAL CENTER   (United States)

^e NONE

Author keywords

Fever; Haemophilus infiuenzae type b; Immunogenicity; Immunosuppression; Malaria; Vaccines

Indexed keywords

HAEMOPHILUS INFLUENZAE TYPE B VACCINE;

ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FEVER; GAMBIA; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; INFANT; MAJOR CLINICAL STUDY; MALARIA; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; VACCINATION;

EID: 0034078731     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-200005000-00010     Document Type: Article

References (37)

1. Todd J, Bruhn FW. Severe Haemophilus influenzae infections, spectrum of disease. Am J Dis Child 1975;19:607-11.
2. Bijlmer HA. World-wide epidemiology of Haemophilus influenzae meningitis; industrialised versus non industrialised countries. Vaccine 1991;9(Suppl):S5-9.
3. Bijlmer HA, Van Alpen L, Greenwood BM, et al. The epidemiology of Haemophilus influenzae meningitis in children under 5 years of age in The Gambia, West Africa. J Infect Dis 1990;161:1210-15.
4. Mulholland EK, Hilton S, Adegbola RA, et al. Randomised trial of Haemophilus influenzae type b-tetanus protein conjugate for prevention of pneumonia and meningitis in Gambian infants. Lancet 1997;349:1191-7.
5. Booy R, Hodgson S, Carpenter L, et al. Efficacy of Haemophilus influenzae type b conjugate vaccine PRP-T. Lancet 1994; 344:362-6.
6. Madore DV. Impact of Immunisation on Haemophilus influenzae type disease. Infect Agents Dis 1996;5:8-20.
7. Adegbola RA, Usen SO, Weber M, et al. Haemophilus influenzae type b meningitis in The Gambia after introduction of a conjugate vaccine. Lancet 1999;354:1091-2.
8. Nussenzweig R. Parasitic disease as a cause of immunosuppression. N Engl J Med 1982;306:423-4.
9. Williamson WA, Greenwood BM. Impairment of the immune response to vaccination after acute malaria. Lancet 1978;1: 1328-9.
10. Tarzaali A, Viens P, Quevillon M. Inhibition of the immune response to whooping cough and tetanus vaccines by malaria infection, and the effect of pertussis adjuvant. Am J Trop Med Hyg 1977;26:520-4.
11. McGregor IA, Barr M. Antibody response to tetanus toxoid inoculation in malarious and non-malarious Gambia children. Trans R Soc Trop Med Hyg 1962;56:364-7.
12. Greenwood BM, Bradley-Moore AM, Palit A, Bryceson ADM. Immunosuppression in children with malaria. Lancet 1972; 1:169-72.
13. Hviid L, Theander TG, Abu-Zeid YA, et al. Loss of cellular immune reactivity during acute Plasmodium falciparum malaria. FEMS Microbiol Immunol 1991;3:219-27.
14. Riley EM, Andersson G, Otoo LN, Jepsen S, Greenwood BM. Cellular immune responses to Plasmodium falciparum antigens in Gambian children during and after an acute attack of falciparum malaria. Clin Exp Immunol 1988;73:17-22.
15. Greenwood BM, Armstrong JRM. Comparison of two simple methods for determining parasite density. Trans R Soc Trop Med Hyg 1991;85:186-8.
16. Greenwood BM, Bradley AK, et al. Mortality and morbidity from malaria among children in a rural area of The Gambia, West Africa. Trans R Soc Trop Med Hyg 1987;81: 478-86.
17. Van Hensbroek MB, Morris-Jones S, Meisner S, et al. Iron, but not folic acid, combined with effective antimalarial therapy promotes haematological recovery in African children after acute falciparum malaria. Trans R Soc Trop Med Hyg 1995;89:672-6.
18. Bodjang KA, Schneider G, Forck S, et al. A trial of Fansidar® plus chloroquine or Fansidar® alone for the treatment of uncomplicated malaria in Gambian children. Trans R Soc Trop Med Hyg 1998;92:73-6.
19. Ward JI, Greenberg DP, Anderson PW, et al. Variable quantification of Haemophilus influenzae type b anticapsular antibody by radioantigen binding assay. J Clin Microbiol 1988;26:72-8.
20. Siegel S, Castellan NJ. Nonparametric statistics for the behavioural sciences. 2nd ed. New York: McGraw Hill, 1988.
21. Conover WJ. Practical nonparametric statistics. 2nd ed. New York: Wiley, 1980.
22. Amemiya T. Tobit model: a survey. J Econometrics 1984;24: 3-61.
23. Alonso PL, Lindsay SW, Armstrong Schellenberg JRM, et al. A malaria control trial using insecticide-treated bed nets and targeted chemoprophylaxis in a rural area of The Gambia, West Africa: the impact of the interventions on mortality and morbidity from The Gambia. Trans R Soc Trop Med Hyg 1993;87(Suppl 2):37-44.
24. Gilles HM, Greenwood BM, Greenwood AM, et al. The Mulumfashi project: an epidemiological, clinical and laboratory study. Trans R Soc Trop Med Hyg 1983;77:24-31.
25. Adegbola RA, Mulholland EK, Falade AG, et al. Haemophilus influenzae type b in theWestern Region of The Gambia: background surveillance for a vaccine efficacy trial. Ann Trop Paediatr 1996;16:103-11.
26. Schneerson R, Barrera O, Sutton A, Robbins JB. Preparation, characterisation, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugate. J Exp Med 1980;152:361-76.
27. Jones B. Co-operation between T and B cells: a minimal model. Immunol Rev 1987;99:5-18.
28. Abbas AK. A reassessment of the mechanism of antigen-specific T-cell dependent B-cell activation. Immunol Today 1988;9:89-94.
29. Dinarello CA. Interleukins, tumour necrosis factors (cachetin), and interferons as endogenous pyrogens and mediators of fever. Lymphokines 1987;14:1-31.
30. Kwiatkowski D, Cannon JG, Manogue KR, Cerami A, Dinarello CA, Greenwood BM. Tumour necrosis factor production in falciparum malaria and its association with schizont rupture. Clin Exp Immunol 1989;77:361-6.
31. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and down regulated by tumour necrosis factor-α. J Exp Med 1994;179:1109-18.
32. Chen B, Shi Y, Smith JD, Choi D, Geiger JD, Mulé JJ. The role of tumor necrosis factor in modulating the quantity of peripheral blood-derived, cytokine-driven human dendritic cell function in presenting soluble antigens to CD4 cells in vitro. Blood 1998;91:4652-61.
33. Steinman RM. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991;9:271-96.
34. Koch F, Kämpgen E, Trockenbenbacher B, Schuler G, Romani N. TNF-α interrupts antigen-presenting function of Langerhans cells by two mechanism: loss of immunogenic peptides and impairment of antigen-independent T cell clustering. Adv Exp Med Biol 1995;378:207-9.
35. Ho M, Webster HK, Looareesuwan S, et al. Antigen-specific immunosuppression in Human Malaria due to Plasmodium falciparum. J Infect Dis 1986;153:763-71.
36. Brasseur P, Agrapart M, Ballet J, Druilhe P, Warrell MJ, Tharavanij S. Impaired cell-mediated immunity in Plasmodium falciparum-infected patients with high parasitaemia and cerebral malaria. Clin Immunol Immunopathol 1983;27:38-50.
37. Lisse IM, Aaby P, Whittle HC, Knudsen K. A community study of T lymphocyte subsets and malaria parasitaemia. Trans R Soc Trop Med Hyg 1994;88:709-10.